Ignite Creation Date:
2025-12-24 @ 10:52 PM
Ignite Modification Date:
2026-01-02 @ 2:21 AM
Study NCT ID:
NCT05427669
Status:
NOT_YET_RECRUITING
Last Update Posted:
2022-10-07
First Post:
2022-06-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Adjuvant mFOLFOXIRI vs. mFOLFOX6 in MRD Positive Stage II-III Colorectal Cancer (AFFORD)
Sponsor:
Yanhong Deng
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-09
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-07-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-07-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-06-17
First Submit QC Date:
None
Study First Post Date:
2022-06-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-06
Last Update Post Date:
2022-10-07
Last Update Post Date Type:
ACTUAL